ADHD

Maternal Hypothyroidism Boosts ADHD Risk

Maternal hypothyroidism in early pregnancy significantly raises the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring, according to a published study.

The Role of Stimulants in ADHD Treatment

In this video, psychiatrist Birgit Amann, MD, discusses the common myth that stimulants are a good treatment option for all patients with attention-deficit/hyperactivity disorder (ADHD).

Emerging Treatment Approaches for ADHD

Psych Congress 2020 cochair Vladimir Maletic, MD, MS, discusses emerging treatments and mechanisms of action for attention deficit/hyperactivity disorder (ADHD).

Anxiety and Mood Disorders in Children and Adolescents With ADHD

Neurodevelopmental pediatrician Frank Lopez, MD, addresses the myth that anxiety and mood disorders do not co-occur with attention-deficit/hyperactivity disorder (ADHD).

Fewer ADHD Symptoms Seen in Girls Active in Youth Sports

Consistent participation in extracurricular sports during the elementary school years predicted fewer attention-deficit/hyperactivity disorder (ADHD) symptoms at age 12 in girls—but not in boys, according to a study in Preventive Medicine.

Investigational Stimulant Improves ADHD Symptoms in Phase 3 Trial

AR19, an investigational stimulant for attention-deficit/hyperactivity disorder (ADHD), improved symptoms in adults with ADHD in a Phase 3 trial, according to a poster presented at Psych Congress 2020.

NDA Accepted for Manipulation-Resistant Stimulant for ADHD

The US Food and Drug Administration has accepted the filing of a New Drug Application for an investigational amphetamine for the treatment of attention-deficit/hyperactivity disorder specifically designed to resist manipulation.

Cannabinoids Not Justified as Mental Health Treatment, Study Says

A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances.

ADHD-Guideline Update Highlights Importance of Addressing Comorbid Conditions

The American Academy of Pediatrics (AAP) has updated its 2011 clinical practice guideline on the evaluation, diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD) in children from age four to 18 years old.

With Parents in Prison, Kids at Risk for Lasting Psychiatric Problems

Children who have a parent in prison may be more than twice as likely as other kids to have depression, attention problems and conduct disorders by the time they reach adolescence, a U.S. study suggests.

Combining Stimulants and Nonstimulants in ADHD Treatment

Anthony L. Rostain, MD, MA, discusses factors to consider when combining stimulants and nonstimulants in the treatment of attention-deficit/hyperactivity disorder (ADHD).

Videos

The Role of Stimulants in ADHD Treatment

In this video, psychiatrist Birgit Amann, MD, discusses the common myth that stimulants are a good treatment option for all patients with attention-deficit/hyperactivity disorder (ADHD).